Your search for

4 results were returned

  1. Twobirds news
    30 May 2019
    International team advises Chiesi Farmaceutici on in-licence of Raxone® from Santhera
    www.twobirds.com/en/news/press-releases/2019/uk/international-team-advises-chiesi-farmaceutici-on-inlicence-of-raxone-from-santhera

    International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")

  2. Twobirds news
    14 October 2019
    Bird & Bird lawyers join EU innovation project SMART- BEAR
    www.twobirds.com/en/news/press-releases/2019/global/bird-and-bird-lawyers-join-eu-innovation-project-smart--bear

    International law firm Bird & Bird joins 26 organisations in a European Commission funded project that draws on big data to improve the health and wellbeing of European citizens. The four-year project aims to build a ...